tiprankstipranks
Trending News
More News >
Cannara Biotech (TSE:LOVE)
:LOVE
Canadian Market

Cannara Biotech (LOVE) Income Statement

Compare
37 Followers

Cannara Biotech Income Statement

Last quarter (Q4 2025), Cannara Biotech's total revenue was C$28.63M, an increase of 24.30% from the same quarter last year. In Q4, Cannara Biotech's net income was C$3.31M. See Cannara Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 25Dec 24Dec 23Dec 22
Total Revenue
C$ 107.32MC$ ―C$ 81.75MC$ 57.26MC$ 35.84M
Gross Profit
C$ 47.22MC$ ―C$ 29.79MC$ 27.23MC$ 17.33M
Operating Expenses
C$ 25.02MC$ ―C$ 19.71MC$ 15.34MC$ 12.36M
Depreciation and Amortization
C$ 6.40MC$ ―C$ 6.35MC$ 4.94MC$ 3.92M
EBITDA
C$ 28.18MC$ ―C$ 15.16MC$ 15.77MC$ 9.54M
Operating Income
C$ 22.20MC$ ―C$ 10.08MC$ 11.89MC$ 3.67M
Other Income/Expenses
C$ -4.10MC$ ―C$ -5.59MC$ -4.94MC$ -2.64M
Pretax Income
C$ 18.10MC$ ―C$ 4.48MC$ 6.95MC$ 2.31M
Net Income
C$ 13.08MC$ ―C$ 6.44MC$ 6.95MC$ 2.31M
Per Share Metrics
Basic EPS
C$ 0.14C$ ―C$ 0.07C$ 0.08C$ 0.03
Diluted EPS
C$ 0.14C$ ―C$ 0.07C$ 0.08C$ 0.03
Weighted Average Shares Outstanding
93.40M 90.07M 89.30M 87.67M
Weighted Average Shares Outstanding (Diluted)
92.37M 91.39M 89.30M 87.84M
Currency in CAD

Cannara Biotech Earnings and Revenue History